We are live on ! Find out more
CDR.PRB

Cedar Realty Trust 7.25% Series B Preferred Stock

1 hedge funds and large institutions have $360K invested in Cedar Realty Trust 7.25% Series B Preferred Stock in 2014 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $356K → $360K (+$3.96K)

0% more funds holding

Funds holding: 11 (0)

0.01% less ownership

Funds ownership: 0.19%0.18% (-0.01%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
HCM
Highlander Capital Management
New Jersey
-$24.8K

CDR.PRB Hedge Fund Activity: Q2 2014 in Review

1 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Cedar Realty Trust 7.25% Series B Preferred Stock (CDR.PRB) for Q2 2014, worth a combined $360K — up 1.1% from $356K a quarter earlier.

Fund positioning in CDR.PRB was balanced in Q2 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Highlander Capital Management, cutting an estimated $24.8K.

  • 1 institutional investor held Cedar Realty Trust 7.25% Series B Preferred Stock (CDR.PRB) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $360K of Cedar Realty Trust 7.25% Series B Preferred Stock stock for Q2 2014, up 1.1% quarter-over-quarter.
  • 0 funds opened new Cedar Realty Trust 7.25% Series B Preferred Stock positions in Q2 2014 and 0 closed out.
  • The largest Cedar Realty Trust 7.25% Series B Preferred Stock seller in Q2 2014 was Highlander Capital Management, an estimated $24.8K sold.

Based on aggregated 13F filings for Q2 2014.